Proposal for a standardised identification of the mono-exponential terminal phase for orally administered drugs-Reference-Cited by-同舟云学术

Proposal for a standardised identification of the mono-exponential terminal phase for orally administered drugs

Published:2008-01 Issue:3 Volume:29 Page:145-157
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Scheerans Christian,Derendorf Hartmut,Kloft Charlotte

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference43 articles.

1. Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products—General Considerations 2003. Food and Drug Administration. http://www.fda.gov/cder/guidance/5356fnl.htm [28 July 2006].

2. Bioavailability and Bioequivalence. In Encyclopedia of Biopharmaceutical Statistics, (ed.). Marcel Decker: New York, 2003; 83–88.

3. Parameters for Compartment-free Pharmacokinetics—Standardisation of Study Design, Data Analysis and Reporting. Shaker Verlag: Aachen, 1999.

4. Noncompartmental Versus Compartmental Modelling in Clinical Pharmacokinetics

5. , . Biopharmazie. Ullstein/Mosby: Berlin/Wiesbaden, 1995.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance characteristics of the adjusted r 2 algorithm for determining the start of the terminal disposition phase and comparison with a simple r 2 algorithm and a visual inspection method;Pharmaceutical Statistics;2019-10-29

2. Proposal for defining the relevance of drug accumulation derived from single dose study data for modified release dosage forms;Biopharmaceutics & Drug Disposition;2015-01-21